Total planned funding: $145,037,142
Allocations
Countries/Regions
India | $145,037,142 |
Organizational Types
Unknown | $52,062,936 |
NGO | $46,834,170 |
Own Agency | $23,833,739 |
University | $8,990,217 |
Private Contractor | $4,098,272 |
Multi-lateral Agency | $3,316,808 |
Implementing Agency | $3,100,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,201,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $69,955,177 |
Prevention | $27,562,834 |
Management and Operations | $18,250,408 |
Care | $12,025,227 |
Treatment | $7,489,454 |
Testing | $5,326,250 |
Budget Codes
OHSS: Health Systems Strengthening | $42,448,706 |
HVSI: Strategic Information | $22,237,587 |
HVMS: Management and Operations | $18,250,408 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,371,273 |
HTXS: Treatment: Adult Treatment | $6,960,959 |
HBHC: Care: Adult Care and Support | $5,369,381 |
HVCT: Testing: HIV Testing and Counseling | $5,326,250 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,272,396 |
HLAB: Laboratory Infrastructure | $5,268,884 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,955,960 |
HVTB: Care: TB/HIV | $3,106,197 |
HKID: Care: Orphans and Vulnerable Children | $3,017,599 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,663,552 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $532,050 |
PDTX: Treatment: Pediatric Treatment | $505,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$52,062,936
Countries/Regions
FHI 360:
$19,853,182
Countries/Regions
USG Aggregated Agencies:
$17,840,840
Countries/Regions
Voluntary Health Services:
$7,060,000
Countries/Regions